Maternal Drug Use and Its Effect on Neonates
Andreea A. Creanga(Johns Hopkins University), L J Paulozzi(National Center for Chronic Disease Prevention and Health Promotion), Patricia E. Taylor(National Center for Chronic Disease Prevention and Health Promotion), Jean Y. Ko(National Center for Chronic Disease Prevention and Health Promotion), Jennifer Sabel(Centers for Disease Control and Prevention), Wanda D. Barfield(National Center for Chronic Disease Prevention and Health Promotion), Carrie K. Shapiro‐Mendoza(Emory University), Laurie Cawthon(Centers for Disease Control and Prevention), Cathy R. Wasserman(Centers for Disease Control and Prevention)
Cited by 12
Related Papers
Racial/Ethnic Disparities in Pregnancy-Related Deaths — United States, 2007–2016
|MMWR Morbidity and Mortality Weekly Report|2019|867
<i>Vital Signs:</i> Pregnancy-Related Deaths, United States, 2011–2015, and Strategies for Prevention, 13 States, 2013–2017
|MMWR Morbidity and Mortality Weekly Report|2019|804
Birth Defects Among Fetuses and Infants of US Women With Evidence of Possible Zika Virus Infection During Pregnancy
|JAMA|2016|781
Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization — United States, 2017–2019
|MMWR Morbidity and Mortality Weekly Report|2022|442
Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021
|Preventing Chronic Disease|2021|370